RDHL RedHill Biopharma Ltd.: institutional ownership and insider trading
14 funds reported holding $264K of RedHill Biopharma Ltd. in their latest 13F filings; in Q2 2026 funds net sold $171K, with 2 new positions and 4 funds selling out; over the last 12 months insiders bought $0 and sold $1.43K on the open market.
Famous investors holding RDHL
- Ken Griffin (Citadel Advisors): $55.2K, 0.0% of the portfolio
Largest institutional holders of RDHL
- Yorkville Advisors Global, LP — $107K
- GAGNON SECURITIES LLC — $74.7K
- CITADEL ADVISORS LLC — $55.2K
- RHUMBLINE ADVISERS — $11.6K
- Lido Advisors, LLC — $9.30K
- CITIGROUP INC (C, C-PN) — $3.70K
- Federation des caisses Desjardins du Quebec — $2.86K
- GAMMA Investing LLC — $138
- UBS Group AG (UBS) — $85
- SBI Securities Co., Ltd. — $10
Recent RDHL insider trades
- Oct 1, 2026: Raday Gilead sold 14,310,000 shares ($1.43K)
- Jul 10, 2026: Raday Gilead sold 14,130,000 shares ($0)
- Apr 6, 2026: Raday Gilead sold 15,740,000 shares ($0)
5%+ owners
- Alumni Capital LP: 10.0% (Schedule 13G, filed Oct 20, 2025)
- YA II PN, Ltd.: 9.9% (Schedule 13G, filed Dec 23, 2025)
Who owns the most RDHL stock?
The largest institutional holders of RedHill Biopharma Ltd. in the latest 13F filings are Yorkville Advisors Global, LP ($107K), GAGNON SECURITIES LLC ($74.7K), CITADEL ADVISORS LLC ($55.2K).
Are insiders buying or selling RDHL?
Over the last 12 months insiders bought $0 and sold $1.43K of RedHill Biopharma Ltd. stock on the open market (SEC Form 4).
Which famous investors own RDHL?
Ken Griffin.